Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 March 2020 | Story Amanda Tongha and Andre Damons | Photo Johan Roux
 UFS postgraduate welcoming
Attending the Postgraduate Welcoming were, from the left: Itumeleng Mutla, second-year master’s student; Prof Corli Witthuhn, Vice-Rector: Research, Innovation and Internationalisation; Prof Witness Mudzi, Director of the Postgraduate School; Hesma van Tonder, Chief Officer: Research Librarian; and John van Niekerk, a master’s student.

The University of the Free State prides itself on being an institution committed to excellence in postgraduate education. In 2019, the UFS boasted more than 6 900 postgraduate students enrolled for postgraduate diplomas, honours, master’s and doctoral qualifications. Of these, 77% previously enrolled at the UFS, while 23% started at the institution for the first time.

Targeting this group of students who make up 17% of the total number of degree-seeking students, the UFS Postgraduate School formally welcomed new senior students to the university on Friday 6 March. 

Postgraduate success
“It is the best time to be a senior student, and I hope it is a wonderful experience,” said Prof Corli Witthuhn, Vice-Rector: Research, Innovation and Internationalisation in her welcoming address to the more than 150 postgraduate students gathered in the Reitz Hall of the Centenary Complex. 

Giving reasons as to why Kovsie students should consider postgraduate studies, Prof Witthuhn said there are many opportunities associated with making the jump from undergraduate to postgraduate student.  

“All the data shows that postgraduate studies increase employability. It creates the opportunity to deeper engage with the field that you are interested in.”
 
The postgraduate journey 
D
r Musawenkosi Saurombe, Senior Lecturer in the Department of Industrial Psychology who became the youngest PhD holder on the African continent at age 23, was also on hand to offer advice. 

“Are you willing to see the task to completion? How badly do you want it?” she challenged postgraduate students, talking about her journey from 16-year old first-year student to 23-year-old doctoral degree holder. 

Itumeleng Mutla, who is in the second year of her master’s degree in Administration, said she found the speech by Dr Saurombe inspiring and encouraging. “I felt like a groupie and took pictures with her afterwards. We felt inspired by her story and she encouraged me in my own studies. I think I am also going to push to finish my studies earlier,” she said.

John van Niekerk, a master’s student in Education and Psychology, said Saurombe’s talk was brilliant and he would like her to give a talk to learners at Kimberley Boys High, where he is a teacher. 

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept